WORK WITH US

Esco Ventures is redefining the therapeutics of tomorrow by supporting life science technologies addressing unmet medical needs. We are looking for passionate individuals who want to transform the life sciences industry.

 

Esco Ventures Fellowship (Morphosis III) – Call for Applicants is now OPEN

Esco Ventures X, Singapore

Esco Ventures is the corporate venture and life science investment arm of Esco Group and is one of the few life science Venture Capital firms in Singapore. Esco Ventures X is our venture (new company) creation platform, and has launched 3 Singapore-based biotech companies, with more therapeutics (drug discovery / development) companies in the works.

 

To further enhance our venture creation portfolio, Esco Ventures X launched the Morphosis Program in 2018, designed for the brightest scientific and budding entrepreneurial minds to embark on biotech venture creation in a VC environment. This full-time program is in 2 phases: in Phase 1 (6 months), Fellows will participate in generating novel venture hypotheses and working closely alongside academic experts and experienced investment professionals in a highly creative and collaborative environment. At the end of Phase 1, the venture hypotheses will be evaluated and selected projects will be incubated by Esco Ventures X over a period of a year, with the selected Fellow(s) embarking on Phase 2 of the program to lead the R&D towards achieving POC. Funding of up to SGD500,000 will be awarded for each selected project. Projects that meet the POC milestones will be incorporated as a new biotech company.

Call for Applicants for Morphosis III will close on 17 April 2020

Research Assistant/Scientist/Senior Scientist

Esco Ventures X, Singapore

Esco Ventures X is incubating exciting new life science and biotech venture companies with first-in-class science addressing unmet medical needs. This position is available for a recently founded biotech company, developing therapeutics for cancer immunotherapy through a proprietary platform technology which enables identification of novel disease targets based on unique biology. The candidate will contribute to development of the platform technology and work closely with the scientific co-founders and management team. The company has a stellar scientific advisory board and is well-capitalized with seed funding to develop first-in-class immunotherapies against cancer.

We are looking for a Research assistant/Scientist/Senior Scientist to join us in this exciting venture. An ideal candidate is one who is independent, technically competent, and able to work efficiently across multiple projects. Individuals with PhD in immunology are preferred. 

Research Associate - CLOSED

Carmine Therapeutics, Singapore

Carmine Therapeutics is an Esco Ventures X company pioneering a powerful new class of drugs based on engineered red blood cells extracellular vesicles (RBCEVs), founded by Esco Ventures and Professors Harvey Lodish, Minh Le and Jiahai Shi. Carmine focuses on developing a therapeutic platform that would address some of the technological unmet needs related to the delivery of next generation therapies such as nucleic acid-based therapeutics. Carmine has assembled a stellar scientific advisory board and is well-capitalized to develop first-in-class therapies against genetic diseases. Carmine is based both in Cambridge, Massachusetts as well as Singapore.

Carmine is looking for a Research Associate to join us in this exciting venture. An ideal candidate is one who is independent, meticulous, technically competent, and able to work efficiently across multiple projects.

Scientist/Senior Scientist (Protein Biochemistry) - CLOSED

Carmine Therapeutics, Singapore

Carmine Therapeutics is an Esco Ventures X company pioneering a powerful new class of drugs based on engineered red blood cells extracellular vesicles (RBCEVs), founded by Esco Ventures and Professors Harvey Lodish, Minh Le and Jiahai Shi. Carmine focuses on developing a therapeutic platform that would address some of the technological unmet needs related to the delivery of next generation therapies such as nucleic acid-based therapeutics. Carmine has assembled a stellar scientific advisory board and is well-capitalized to develop first-in-class therapies against genetic diseases. Carmine will be based in Singapore but also with operations in Cambridge, Massachusetts.

Carmine is looking for a Scientist/Senior Scientist to join us in this exciting venture. An ideal candidate is one who is independent, technically competent, and able to work efficiently across multiple projects. Individuals with PhD in protein biochemistry are preferred. This role may involve a relocation to Cambridge, Massachusetts and therefore candidates should ideally be Singaporeans or US citizens.

Scientist/Senior Scientist (Hematology/Immunology) - CLOSED

Carmine Therapeutics, Singapore

Carmine Therapeutics is an Esco Ventures X company pioneering a powerful new class of drugs based on engineered red blood cells extracellular vesicles (RBCEVs), founded by Esco Ventures and Professors Harvey Lodish, Minh Le and Jiahai Shi. Carmine focuses on developing a therapeutic platform that would address some of the technological unmet needs related to the delivery of next generation therapies such as nucleic acid-based therapeutics. Carmine has assembled a stellar scientific advisory board and is well-capitalized to develop first-in-class therapies against genetic diseases. Carmine will be based in Singapore but also with operations in Cambridge, Massachusetts.

Carmine is looking for a Scientist/Senior Scientist to join us in this exciting venture. An ideal candidate is one who is independent, technically competent, and able to work efficiently across multiple projects. Individuals with PhD in hematology or immunology are preferred. This role may involve a relocation to Cambridge, Massachusetts and therefore candidates should ideally be Singaporeans or US citizens.

Esco Ventures Fellowship – Call for Applicants is now CLOSED

Esco Ventures X, Singapore

Esco Ventures X launched the Morphosis Program in 2018, designed for the brightest scientific and budding entrepreneurial minds to embark on biotech venture creation in a VC environment. This full-time program is in 2 phases: in Phase 1 (6 months), Fellows will participate in generating novel venture hypotheses and working closely alongside academic experts and experienced investment professionals in a highly creative and collaborative environment. At the end of Phase 1, the venture hypotheses will be evaluated and selected projects will be incubated by Esco Ventures X over a period of a year, with the selected Fellow(s) embarking on Phase 2 of the program to lead the R&D towards achieving POC.

Call for Applicants for Morphosis II will close on 31 July 2019

Scientist (RNA & Molecular Biology) - CLOSED

Carmine Therapeutics, Singapore

Carmine Therapeutics is an Esco Ventures X company pioneering a powerful new class of drugs based on engineered red blood cells extracellular vesicles (RBCEVs), founded by Esco Ventures and Professors Harvey Lodish, Minh Le and Jiahai Shi. Carmine focuses on developing a therapeutic platform that would address some of the technological unmet needs related to the delivery of next generation therapies such as nucleotide-based drugs. Carmine has assembled a stellar scientific advisory board and is well-capitalized to develop first-in-class therapies against rare diseases and cancer. Carmine will be based in Singapore but also with operations in Cambridge, Massachusetts.

Carmine is looking for a Scientist to join us in this exciting venture. The candidate must be independent, technically competent and able to efficiently work across multiple projects. The ideal candidate is one who is energetic, innovative and highly motivated, with experience working with RNA and familiar with a wide variety of molecular biology techniques.

Scientist (Cell Biology) - CLOSED

Carmine Therapeutics, Singapore

Carmine Therapeutics is an Esco Ventures X company pioneering a powerful new class of drugs based on engineered red blood cells extracellular vesicles (RBCEVs), founded by Esco Ventures and Professors Harvey Lodish, Minh Le and Jiahai Shi. Carmine focuses on developing a therapeutic platform that would address some of the technological unmet needs related to the delivery of next generation therapies such as nucleotide-based drugs. Carmine has assembled a stellar scientific advisory board and is well-capitalized to develop first-in-class therapies against rare diseases and cancer. Carmine will be based in Singapore but also with operations in Cambridge, Massachusetts.

Carmine is looking for a Scientist to join us in this exciting venture. The candidate must be independent, technically competent and able to efficiently work across multiple projects. The ideal candidate is one who is energetic, innovative and highly motivated, with experience in cell biology and working with animal disease models.

Analyst/Associate - CLOSED

Esco Ventures, Singapore

Esco Ventures is the corporate venture and life science investment arm of Esco Group. We invest in life sciences tools & diagnostics, women’s health & fertility and biotech (with a focus on enabling platform technologies), operating across Singapore, China and the US.

 

We have an opening for an analyst or associate (depending on experience). This is a perfect entry-level opportunity for a recent PhD graduate or junior Post Doc aiming at a career in venture capital.

Senior Research Scientist - CLOSED

Esco Ventures X, Singapore

Esco Ventures X is incubating exciting new life science and biotech venture companies with first-in-class science addressing unmet medical needs. A position is available for a Senior Research Scientist to participate in the development of a new platform technology drug discovery company.

Machine Learning / Artificial Intelligence Scientist - CLOSED

Singapore

Esco Ventures is incubating exciting new life science and biotech venture companies with first in class science addressing unmet medical needs. A position is available for a Machine Learning / Artificial Intelligence Scientist to participate in various innovative projects of the company with regards to problem formulation, model development, and such. The Machine Learning / Artificial Intelligence Scientist will work closely with all members of the Esco Ventures team as well as our Singapore based CEO and stand chances of potential stock options.

Venture Partner

Europe

Esco Ventures is the corporate venture and life science investment arm of Esco Group, which invests globally in therapeutics, diagnostics, life science tools and medical devices. We are looking to expand our footprint in Europe and looking for a Europe-based Venture Partner to scout, evaluate and lead deals; and network with academic TTOs, VCs and corporate partners in Europe.

Life Sciences Tools Entrepreneur-in-Residence

Singapore

Esco Ventures is seeking a Life Sciences Tools/Diagnostics platforms Entrepreneur-in-Residence to evaluate investment opportunities, filter unmet needs, scout/invent technologies, and launch/co-found a new internally created venture to develop a novel life sciences (and preferably diagnostics platform) technology, leading the R&D team/program for the new venture.

Scientist – Molecular and Cell Biology

Esco Ventures X, Singapore

Esco Ventures X (EVX) is a biotech venture builder that is dedicated to nurturing promising early-stage startups with novel innovations and technologies in the life sciences arena that will improve human well-being and quality of life. EVX co-founds and invests in biotech startups with inventors and is deeply involved in all aspects of company formation, including assembling the team, business and research and development operations.

EVX is looking for an accomplished Scientist to join us in the incubation of an exciting new potential venture. The candidate must be independent, technically competent and able to efficiently work with project timelines. The ideal candidate is one who is energetic, innovative and highly motivated, with strong expertise in molecular and cell biology.

Research Associate

Carmine Therapeutics, Singapore

Carmine Therapeutics is an Esco Ventures X company pioneering a powerful new class of drugs based on engineered red blood cells extracellular vesicles (RBCEVs), founded by Esco Ventures and Professors Harvey Lodish, Minh Le and Jiahai Shi. Carmine focuses on developing a therapeutic platform that would address some of the technological unmet needs related to the delivery of next generation therapies such as nucleic acids. Carmine was awarded the 2019 Bristol-Myers Squibb’s Golden Ticket to LabCentral (Cambridge, MA), and is well-capitalized to develop first-in-class therapies against genetic diseases. Carmine is based both in Cambridge, MA as well as Singapore.

The Discovery Team in Carmine Singapore is looking for a Research Associate to join us in this exciting venture. An ideal candidate is one who is independent, meticulous, technically competent, and able to work efficiently across multiple projects.

CONTACT US

SIGN UP FOR OUR NEWSLETTER

  • LinkedIn - White Circle

SINGAPORE

LaunchPad @ one-north

71 Ayer Rajah Crescent

#03-20/21/23/24

Singapore 139951

UNITED STATES

Cambridge Innovation Center

One Broadway, Kendall Square

Cambridge MA 02142

CHINA

Biotech Innovation Works

No.29 Life Park Road

Room 202-010, Block D

Changping District, Beijing, China, 102206

© 2020 by Esco Ventures Pte. Ltd.